As research continues, those involved say this would be a game changer, especially for patients with very limited options.

As research continues, those involved say this would be a game changer, especially for patients with very limited options.

As research continues, those involved say this would be a game changer, especially with patients with minimal options. Greg Jicha, M.D., Ph.D., is a neurologist and director of clinical trials at UK’s ...

Researchers at the University of Kentucky are part of a groundbreaking clinical trial exploring the use of medical marijuana in managing symptoms of late-stage dementia. The National Institutes of ...

Greg Jicha, M.D., Ph.D., a neurologist and director of clinical trials at UK’s Sanders-Brown Center on Aging, says there is a pressing need for alternative treatments. Research reported in this ...

Researchers at the University of Kentucky are part of a groundbreaking clinical trial exploring the use of medical marijuana in managing symptoms of late-stage dementia. The National Institutes of ...

Greg Jicha, M.D., Ph.D., a neurologist and director of clinical trials at UK’s Sanders-Brown Center on Aging, says there is a pressing need for alternative treatments. “Until we find a cure ...

UK has made key contributions to LATE research, including being home to the world's only clinical trial of a drug targeting LATE led by the Sanders-Brown's director of clinical trials Greg Jicha ...

This is one of the first studies to run since Kentucky legalized medical marijuana. Greg Jicha, M.D., Ph.D., a neurologist and director of clinical trials at UK’s Sanders-Brown Center on Aging, said ...